🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A substance called integrin alpha v beta six (αvβ6) is found to be increase...
Status
Completed
Location
Barts Health NHS Trust
Start Date
2016-03-17
Trial ID
NCT04285996
Treatments Being Tested
Aim: To evaluated if cladribine based conditioning (CBA) could decrease rel...
Status
Unknown
Location
Shanghai general hospital, Shanghai Jiaotong university school of medicine
Start Date
2016-08-01
Trial ID
NCT03384225
Treatments Being Tested
Unrelated matched donor (cord blood, bone marrow or peripheral blood) allog...
Status
Terminated
Location
Columbia University Medical Center
Start Date
2002-11
Trial ID
NCT01050439
The purpose of this study is to demonstrate the feasibility of the Elopemen...
Status
Completed
Location
Marcus Autism Center
Start Date
2015-02
Trial ID
NCT02383732
The purpose of this study is to determine if a reduced intensity (RI) (non-...
Status
Terminated
Location
Columbia University Medical Center
Start Date
2007-08
Trial ID
NCT00684255
Treatments Being Tested
Accumulating evidence is showing that gut microbiota could play a key role ...
Status
Completed
Location
University of Naples Federico II
Start Date
2012-01-09
Trial ID
NCT04491266
This is a multicentre, pilot study that aims to determine the feasibility o...
Status
Withdrawn
Location
Barts Health NHS Trust
Start Date
2018-06-19
Trial ID
NCT06978478
Treatments Being Tested
Children on the autism spectrum often show aggressive behavior. Treatment c...
Status
Completed
Location
De Bascule
Start Date
2011-01-01
Trial ID
NCT05221515
Treatments Being Tested
Aim: To evaluated if cladribine based conditioning (CBA) could decrease rel...
Status
Unknown
Location
Shanghai general hospital, Shanghai Jiaotong university school of medicine
Start Date
2016-08-01
Trial ID
NCT03384212
Treatments Being Tested
GSK3008348 is being developed as a treatment for IPF. A first-time-in-human...
Status
Terminated
Location
GSK Investigational Site
Start Date
2017-06-13
Trial ID
NCT03069989
Treatments Being Tested